Deletion of Asah2 alleviates diet-induced nonalcoholic steatohepatitis/nonalcoholic fatty liver disease via downregulation of stearoyl-CoA desaturase (Scd1) and reduces cholesterol accumulation (75). Here, ASAH2 is linked to metabolic dysfunction-associated steatohepatitis.